Dynamic proteomic and phosphoproteomic atlas of corticostriatal axons in neurodevelopment
- Northwestern University, United States
- University of Pittsburgh, United States
Abstract
Mammalian axonal development begins in embryonic stages and continues postnatally. After birth, axonal proteomic landscape changes rapidly, coordinated by transcription, protein turnover, and post-translational modifications. Comprehensive profiling of axonal proteomes across neurodevelopment is limited, with most studies lacking cell-type and neural circuit specificity, resulting in substantial information loss. We create a Cre-dependent APEX2 reporter mouse line and map cell-type specific proteome of corticostriatal projections across postnatal development. We synthesize analysis frameworks to define temporal patterns of axonal proteome and phosphoproteome, identifying co-regulated proteins and phosphorylations associated with genetic risk for human brain disorders. We discover proline-directed kinases as major developmental regulators. APEX2 transgenic reporter proximity labeling offers flexible strategies for subcellular proteomics with cell type specificity in early neurodevelopment, a critical period for neuropsychiatric disease.
Data availability
Mass spectrometry raw data have been deposited in the PRIDE database (accession number: PXD030864. Code is available at Github (link in Materials and Methods). All analyzed proteomics results are also included as supplementary files. All uncropped gels and blots are included as source data.
Article and author information
Author details
Vasin Dumrongprechachan
Yevgenia Kozorovitskiy
Funding
National Institute of Mental Health (R56MH113923)
- Yevgenia Kozorovitskiy
American Heart Association (19PRE34380056)
- Vasin Dumrongprechachan
National Institute of General Medical Sciences (2T32GM15538)
- Vasin Dumrongprechachan
National Institute of Neurological Disorders and Stroke (R01NS107539)
- Yevgenia Kozorovitskiy
National Institute of Mental Health (R01MH117111)
- Yevgenia Kozorovitskiy
National Science Foundation (1846234)
- Yevgenia Kozorovitskiy
Arnold and Mabel Beckman Foundation (Beckman Young Investigator Award)
- Yevgenia Kozorovitskiy
Kinship Foundation (Searle Scholar Award)
- Yevgenia Kozorovitskiy
Rita Allen Foundation (Rita Allen Foundation Scholar Award)
- Yevgenia Kozorovitskiy
Alfred P. Sloan Foundation (Sloan Research Fellowship)
- Yevgenia Kozorovitskiy
National Institute of Mental Health (R01MH118497)
- Matthew L MacDonald
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Animals were handled according to protocols approved by the Northwestern University AnimalCare and Use Committee. (protocol number: IS00008060).
Copyright
© 2022, Dumrongprechachan et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,482
- views
-
- 379
- downloads
-
- 10
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Dynamic proteomic and phosphoproteomic atlas of corticostriatal axons in neurodevelopment
eLife 11:e78847.
https://doi.org/10.7554/eLife.78847
Further reading
-
- Neuroscience
By influencing calcium homeostasis, local protein synthesis and the endoplasmic reticulum, a small protein called Rab10 emerges as a crucial cytoplasmic regulator of neuropeptide secretion.
-
- Neuroscience
Millions of Americans suffering from Opioid Use Disorders face a high risk of fatal overdose due to opioid-induced respiratory depression (OIRD). Fentanyl, a powerful synthetic opioid, is a major contributor to the rising rates of overdose deaths. Reversing fentanyl overdoses has proved challenging due to its high potency and the rapid onset of OIRD. We assessed the contributions of central and peripheral mu opioid receptors (MORs) in mediating fentanyl-induced physiological responses. The peripherally restricted MOR antagonist naloxone methiodide (NLXM) both prevented and reversed OIRD to a degree comparable to that of naloxone (NLX), indicating substantial involvement of peripheral MORs to OIRD. Interestingly, NLXM-mediated OIRD reversal did not produce aversive behaviors observed after NLX. We show that neurons in the nucleus of the solitary tract (nTS), the first central synapse of peripheral afferents, exhibit a biphasic activity profile following fentanyl exposure. NLXM pretreatment attenuates this activity, suggesting that these responses are mediated by peripheral MORs. Together, these findings establish a critical role for peripheral MORs, including ascending inputs to the nTS, as sites of dysfunction during OIRD. Furthermore, selective peripheral MOR antagonism could be a promising therapeutic strategy for managing OIRD by sparing CNS-driven acute opioid-associated withdrawal and aversion observed after NLX.
